昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

06127 昭衍新药

休市中 07-03 16:08:15

19.490

+0.490

+2.58%

最高19.750	最低18.830	成交量378.74万
今开19.280	昨收19.000	日振幅4.84%
总市值145.98亿	流通市值23.19亿	总股本7.49亿
成交额7,315万	换手率3.18%	流通股本1.19亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":19.49,"timestamp":1783066095007,"preClose":19,"halted":0,"volume":3787364,"delay":0,"changeRate":0.025789473684210446,"floatShares":118995206,"shares":749000000,"eps":0.46245930574622474,"marketStatus":"休市中","change":0.49,"latestTime":"07-03 16:08:15","open":19.28,"high":19.75,"low":18.83,"amount":73146481,"amplitude":0.048421,"askPrice":19.49,"askSize":8000,"bidPrice":19.48,"bidSize":1400,"shortable":3,"etf":0,"ttmEps":0.7892538618552657,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1783301400000},"marketStatusCode":7,"adr":0,"listingDate":1614268800000,"exchange":"SEHK","adjPreClose":19,"dividendRate":0.007104,"openAndCloseTimeList":[[1783042200000,1783051200000],[1783054800000,1783065600000]],"volumeRatio":0.7012928471510336,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":40.56,"timestamp":1783062000000,"preClose":39.62,"halted":0,"volume":30991900,"delay":0,"premium":"-58.44"}},"requestUrl":"/m/hq/s/06127","defaultTab":"news","newsList":[{"id":"2649694371","title":"每周股票复盘：昭衍新药（603127）H股与A股股本及股份无变动","url":"https://stock-news.laohu8.com/highlight/detail?id=2649694371","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2649694371?lang=zh_cn&edition=full","pubTime":"2026-07-05 01:55","pubTimestamp":1783187711,"startTime":"0","endTime":"0","summary":"昭衍新药当前最新总市值303.94亿元，在医疗服务板块市值排名7/51，在两市A股市值排名706/5203。本周关注点公司公告汇总：H股与A股法定/注册股本、已发行股份及库存股份数目均无变动公司公告汇总H股公告：6月月报表北京昭衍新药研究中心股份有限公司提交截至2026年6月30日的证券变动月报表，H股和A股的法定/注册股本、已发行股份及库存股份数目均无变动。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070500000432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","399300","BK1576","BK1141","159982","603127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1150938065","title":"昭衍新药6月股份变动月报出炉，股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1150938065","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1150938065?lang=zh_cn&edition=full","pubTime":"2026-07-03 15:08","pubTimestamp":1783062525,"startTime":"0","endTime":"0","summary":"北京昭衍新药研究中心股份有限公司于2026年7月3日发布2026年6月股份变动月报表，就截至2026年6月30日的股本结构及变化进行披露。公告显示，昭衍新药拥有普通股H股118,995,206股，普通股A股630,353,014股，两类股份合计749,348,220股。本月期间，公司普通股A股与H股均无新增发行、股份购回或注销，股本数量保持不变，且无股份期权、权证、可转换债券及其他股份相关协议或安排的变动。根据公告，昭衍新药的H股已满足香港联交所适用的公众持股量要求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647121324","title":"6月29日昭衍新药涨6.80%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647121324","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647121324?lang=zh_cn&edition=full","pubTime":"2026-06-29 16:32","pubTimestamp":1782721945,"startTime":"0","endTime":"0","summary":"证券之星消息，6月29日昭衍新药涨6.80%，收盘报39.6元，换手率6.58%，成交量41.46万手，成交额16.23亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900024250.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","BK0216","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647003329","title":"昭衍新药：公司目前暂未有回购A股股份的计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2647003329","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647003329?lang=zh_cn&edition=full","pubTime":"2026-06-29 15:37","pubTimestamp":1782718671,"startTime":"0","endTime":"0","summary":"证券之星消息，昭衍新药(603127)06月29日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，现阶段同行业各家公司都在回购股票，公司是否有计划回购股票，请直接回答有或者没有。昭衍新药回复：您好！公司目前暂未有回购A股股份的计划，如有，会按照相关规定履行信息披露义务。公司曾于2024年披露了关于A股股份回购的计划并于2025年实施完成，具体请查阅公司披露的相关公告。感谢关注！本文数据来源于上海证券交易所e互动，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062900017730.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK1141","BK0216","399300","159982","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647325211","title":"港股异动 | CRO概念股涨幅居前 长期看AI将引发行业变革 研发端或分化而生产端整体受益","url":"https://stock-news.laohu8.com/highlight/detail?id=2647325211","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647325211?lang=zh_cn&edition=full","pubTime":"2026-06-29 14:28","pubTimestamp":1782714533,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SG9999002463.SGD","LU0039217434.USD","BK1191","IE00B0JY6N72.USD","LU1242518857.USD","LU0823426480.USD","LU0456827905.SGD","LU0052750758.USD","LU0823426308.USD","LU0307460666.USD","LU0516423174.USD","LU0516422366.SGD","LU0417516902.SGD","LU0572944931.SGD","LU0516423091.SGD","BK1521","LU0516422952.EUR","LU1046422090.SGD","LU1688375341.USD","LU0140636845.USD","LU2125910500.SGD","LU0819121731.USD","LU3063872942.SGD","02269","LU1880383366.USD","SG9999002562.SGD","LU0417516738.SGD","LU0516422440.USD","LU0708995583.HKD","LU1720050803.USD","LU0043850808.USD","BK1589","LU0327786744.USD","06127","LU0051755006.USD","LU1794554557.SGD","LU2045819591.USD","LU0979878070.USD","LU0326950275.SGD","02359","LU0359202008.SGD","BK1583","LU2242644610.SGD","LU2039709279.SGD","LU0359201612.USD","06821","LU0456846285.SGD","LU0588546209.SGD","LU0856984785.SGD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647475973","title":"港股医药股走强 昭衍新药涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2647475973","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647475973?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:26","pubTimestamp":1782699986,"startTime":"0","endTime":"0","summary":"6月29日，截至发稿，昭衍新药(06127.HK)涨8.55%，凯莱英(06821.HK)涨7.64%，康龙化成(03759.HK)涨7.51%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606293786079564.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606293786079564.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK0216","BK1576","159718","BK1141","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647034208","title":"医药外包概念走强 昭衍新药(06127)涨9.16% 机构指相关标的业绩有望超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=2647034208","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2647034208?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:20","pubTimestamp":1782699626,"startTime":"0","endTime":"0","summary":"消息面上，东吴证券研究指，22家CXO上市公司2026Q1实现收入、归母净利润、扣非归母净利润总额增速分别同比增长18.6%、21.9%、63.5%，业绩逐季度改善。根据医药魔方，2026Q1，国内创新药一级市场融资总金额25.9亿美元，同比上涨128.6%，2026Q1中国相关交易数量及金额涨势迅猛，总金额达614亿美元，大幅领先国外交易总金额。该机构认为，随着中国创新药在全球研发创新中的比重提升，与其配套的CXO产业链将进一步增强。","market":"sh","thumbnail":"https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ODBhOTU0MzI3NjMwOTM5MjE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984678","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU1242518931.SGD","HK0000306701.USD","LU0181495838.USD","LU0348767384.USD","06821","LU0052750758.USD","LU1046422090.SGD","LU0140636845.USD","LU1794554557.SGD","LU1880383366.USD","02359","LU0417516738.SGD","159938","LU0516422952.EUR","LU0456846285.SGD","LU2045819591.USD","BK1574","LU0320764599.SGD","03347","LU0348766576.USD","LU0043850808.USD","LU0417516902.SGD","603127","LU2125910500.SGD","BK1583","BK1161","LU0348735423.USD","LU0823426308.USD","LU0359202008.SGD","LU1688375341.USD","LU1720050803.USD","LU2242644610.SGD","06127","HK0000320223.HKD","09939","BK0216","BK1191","BK1576","LU3063872942.SGD","BK1141","01548","LU0348825331.USD","LU0979878070.USD","HK0000320264.USD","LU0588546209.SGD","LU0708995583.HKD","HK0000306685.HKD","03759","02269"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866019","title":"CXO概念走强 凯莱英 (06821) 涨 17.77% BIO2026大会看好中国CXO高效率优势","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866019","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866019?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:17","pubTimestamp":1782271026,"startTime":"0","endTime":"0","summary":"全球生物技术领域盛会BIO2026大会于6月22日至25日在美国圣地亚哥召开，汇聚全球超20000名行业参与者，覆盖人工智能与数字健康、细胞与基因治疗等前沿领域，中国CXO企业的高效率优势备受关注。光大证券研报指，2026年6月22日至25日BIO2026大会举办，70余个国家超2万名业内人士参会，覆盖18大生物医药核心议题，凯莱英、泰格医药、博腾股份等国内CXO企业参展，英硅智能同期落地AI药物研发海外合作。","market":"fut","thumbnail":"https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/ZDQyZmM0MDNhYTRlOWFhOWE0NDBjZGFmOTc4ZmU3NDQzMjc2MzA4MTk4NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984377","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0348735423.USD","LU1880383366.USD","BK0132","LU0348766576.USD","LU0819121731.USD","LU0359202008.SGD","02269","HK0000320223.HKD","HK0000306701.USD","01548","LU2039709279.SGD","LU0359201612.USD","LU0043850808.USD","LU3063872942.SGD","LU0327786744.USD","LU0572944931.SGD","LU0326950275.SGD","HK0000320264.USD","LU0052750758.USD","03347","LU1242518931.SGD","LU0320764599.SGD","LU0456846285.SGD","LU0516422952.EUR","06127","HK0000306685.HKD","BK1141","BK0239","06821","CXO","BK1583","LU0039217434.USD","LU1046422090.SGD","SG9999002463.SGD","BK1521","BK1576","LU0516422366.SGD","LU1794554557.SGD","LU2242644610.SGD","LU1328615791.USD","02359","LU0708995583.HKD","LU0588546209.SGD","LU0856984785.SGD","LU0456827905.SGD","LU1720050803.USD","002821","03759","LU0140636845.USD","LU0051755006.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645866072","title":"CRO概念股震荡走高","url":"https://stock-news.laohu8.com/highlight/detail?id=2645866072","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645866072?lang=zh_cn&edition=full","pubTime":"2026-06-24 11:11","pubTimestamp":1782270685,"startTime":"0","endTime":"0","summary":"CRO概念股震荡走高","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606243781168150.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606243781168150.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1191","BK1141","06821","06127","03347","BK1583","BK1576","03759"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645325718","title":"昭衍新药（603127）披露调整2026年A股限制性股票激励计划授予价格公告，6月23日股价下跌0.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2645325718","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645325718?lang=zh_cn&edition=full","pubTime":"2026-06-23 22:16","pubTimestamp":1782224182,"startTime":"0","endTime":"0","summary":"截至2026年6月23日收盘，昭衍新药报收于36.53元，较前一交易日下跌0.38%，最新总市值为273.74亿元。该股当日开盘36.66元，最高38.28元，最低36.03元，成交额达12.23亿元，换手率为5.21%。近日，北京昭衍新药研究中心股份有限公司召开第五届董事会第五次会议，审议通过了《关于调整2026年A股限制性股票激励计划授予价格的议案》。本次调整已获股东会授权，无需提交股东会审议。董事会薪酬与考核委员会及律师均认为调整程序合法合规，未损害公司及股东利益。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062300042456.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK1141","159982","BK1576","603127","BK0216","399300"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645602593","title":"6月22日昭衍新药发布公告，股东减持2248.02万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645602593","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645602593?lang=zh_cn&edition=full","pubTime":"2026-06-22 18:01","pubTimestamp":1782122474,"startTime":"0","endTime":"0","summary":"证券之星消息，6月22日昭衍新药发布公告《昭衍新药:昭衍新药股东减持A股股份结果公告》，其股东顾美芳、顾晓磊于2026年4月7日至2026年6月18日间合计减持2248.02万股，占公司目前总股本的3.0%，变动期间该股股价下跌2.57%，截止6月18日收盘报35.66元。股东增减持详情见下表：根据昭衍新药2026年一季报公布的十大股东详情如下：本文数据来源于昭衍新药公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062200027429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","603127","BK1141","BK1576","06127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645235360","title":"昭衍新药(06127)：股东顾晓磊、顾美芳分别减持1506.18万股、741.84万股 减持计划实施完毕","url":"https://stock-news.laohu8.com/highlight/detail?id=2645235360","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2645235360?lang=zh_cn&edition=full","pubTime":"2026-06-22 17:37","pubTimestamp":1782121057,"startTime":"0","endTime":"0","summary":"顾晓磊及其一致行动人顾美芳合计减持不超过公司总股本的3.00%。截至2026年6月18日，顾晓磊、顾美芳分别减持1506.18万股、741.84万股，减持计划实施完毕。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1456958.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06127","BK1576","BK0216","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644057237","title":"6月18日昭衍新药涨9.99%，易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2644057237","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644057237?lang=zh_cn&edition=full","pubTime":"2026-06-18 16:32","pubTimestamp":1781771578,"startTime":"0","endTime":"0","summary":"证券之星消息，6月18日昭衍新药涨9.99%，收盘报35.66元，换手率4.38%，成交量27.59万手，成交额9.52亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共44家，其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800028604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","BK0216","BK1141","BK1576","603127"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644779578","title":"异动快报：昭衍新药（603127）6月18日11点9分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2644779578","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644779578?lang=zh_cn&edition=full","pubTime":"2026-06-18 11:15","pubTimestamp":1781752533,"startTime":"0","endTime":"0","summary":"证券之星6月18日盘中消息，11点9分昭衍新药（603127）触及涨停板。其所属行业医疗服务目前上涨。领涨股为皓元医药。该股为CAR-T疗法，创新药，基因编辑概念热股，当日CAR-T疗法概念上涨2.55%，创新药概念上涨2.45%，基因编辑概念上涨2.42%。6月17日的资金流向数据方面，主力资金净流出3896.52万元，占总成交额8.92%，游资资金净流入240.98万元，占总成交额0.55%，散户资金净流入3655.55万元，占总成交额8.37%。近5日资金流向一览见下表：昭衍新药主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061800015892.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","06127","BK0216","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644307776","title":"医药外包概念回暖 昭衍新药(06127)涨4.47%、药明康德(02359)涨3.35%","url":"https://stock-news.laohu8.com/highlight/detail?id=2644307776","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644307776?lang=zh_cn&edition=full","pubTime":"2026-06-18 10:15","pubTimestamp":1781748909,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念回暖，截至发稿，昭衍新药 涨4.47%，药明康德涨3.35%，药明生物涨2.75%，金斯瑞生物科技涨2.31%，凯莱英涨1.24%，康龙化成涨1.06%。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/MzQyYjVhODQ3ZWY1M2M1MGY5NWIyMTYzODE1MzIxNzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1984065","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["603127","LU2488822045.USD","LU0516422366.SGD","LU1242518931.SGD","06127","IE00BPRC5H50.USD","02359","01548","LU0348735423.USD","IE00B543WZ88.USD","LU0359202008.SGD","LU1979443071.USD","LU1997244956.HKD","LU2045819591.USD","02269","SG9999002463.SGD","IE00B5MMRT66.SGD","BK1161","IE00B0JY6N72.USD","LU0307460666.USD","LU0326950275.SGD","LU0588546209.SGD","LU0823426480.USD","BK1521","LU0979878070.USD","LU0140636845.USD","LU1997245094.SGD","LU0327786744.USD","LU0516422440.USD","LU1046422090.SGD","LU1688375341.USD","BK1589","159938","LU2495084118.USD","09939","03759","LU1303224171.USD","BK1141","BK1574","LU0359201612.USD","LU0051755006.USD","LU0572944931.SGD","SG9999002562.SGD","LU0516422952.EUR","LU0348767384.USD","603259","06821","LU1251922891.USD","BK1515","LU0456846285.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644761086","title":"股市必读：昭衍新药（603127）6月16日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2644761086","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644761086?lang=zh_cn&edition=full","pubTime":"2026-06-17 01:40","pubTimestamp":1781631620,"startTime":"0","endTime":"0","summary":"截至2026年6月16日收盘，昭衍新药报收于32.38元，下跌1.1%，换手率2.42%，成交量15.28万手，成交额4.93亿元。董秘最新回复投资者： 您好，公司在建安评基地有哪些董秘： 您好！公司正在建设的安评基地主要是在广州。当日关注点交易信息汇总：6月16日主力资金净流出2165.81万元，占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061700000634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","BK1576","06127","603127","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643217925","title":"每周股票复盘：昭衍新药（603127）两日大宗交易超1.97亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2643217925","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2643217925?lang=zh_cn&edition=full","pubTime":"2026-06-14 01:20","pubTimestamp":1781371224,"startTime":"0","endTime":"0","summary":"截至2026年6月12日收盘，昭衍新药报收于32.52元，较上周的32.6元下跌0.25%。本周，昭衍新药6月12日盘中最高价报32.93元。6月9日盘中最低价报30.7元。昭衍新药当前最新总市值243.69亿元，在医疗服务板块市值排名7/51，在两市A股市值排名861/5206。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061400000206.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1576","BK1141","603127","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642200466","title":"6月9日昭衍新药发生1笔大宗交易 成交金额1.28亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2642200466","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642200466?lang=zh_cn&edition=full","pubTime":"2026-06-09 17:48","pubTimestamp":1780998517,"startTime":"0","endTime":"0","summary":"证券之星消息，6月9日昭衍新药发生大宗交易，交易数据如下：大宗交易成交价格29.8元，相对当日收盘价折价5.19%，成交429万股，成交金额12784.2万元，买方营业部为中信证券股份有限公司江苏分公司，卖方营业部为华泰证券股份有限公司太仓太平南路证券营业部。近三个月该股共发生13笔大宗交易，合计成交12.66万手，折价成交13笔。截至2026年6月9日收盘，昭衍新药报收于31.43元，上涨0.19%，换手率2.12%，成交量13.34万手，成交额4.16亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060900029235.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1141","BK1576","603127","06127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641105779","title":"医药外包概念股全线走低 金斯瑞生物科技(01548)跌7.43%、药明生物(02269)跌7.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2641105779","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641105779?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:43","pubTimestamp":1780897412,"startTime":"0","endTime":"0","summary":"中邮证券表示，2026年第一季度，海外CXO行业整体呈现分化复苏格局，全球生物制药融资环境出现实质性改善，带动需求逐步回暖，但早期初创企业资金压力仍未完全缓解，不同细分赛道、不同规模企业的表现存在差异，行业结构性分化特征进一步凸显。展望2026年，海外头部CXO企业收入指引仍维持稳健小幅增长格局，叠加全球生物医药投融资逐步回暖、创新药研发需求稳步复苏，行业景气度延续上行态势，成长确定性进一步增强。","market":"hk","thumbnail":"https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/NDE0ZmVkNmQ0OWQ1YWQ5ZWU5ODBlOTBjYzlmMjcxMzI0MDU1NzE=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1983281","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359201612.USD","LU0856984785.SGD","03759","LU0417516902.SGD","LU0456827905.SGD","BK1521","03347","LU0348735423.USD","LU0708995583.HKD","LU1880383366.USD","06127","LU0516422440.USD","LU2039709279.SGD","LU0516422952.EUR","LU0140636845.USD","02359","09939","LU0417516738.SGD","LU0326950275.SGD","BK1515","BK1574","LU0348766576.USD","01521","LU1688375341.USD","HK0000306685.HKD","LU0051755006.USD","LU1720050803.USD","BK1191","06821","02269","BK1589","LU0320764599.SGD","LU3063872942.SGD","LU0516422366.SGD","SG9999002463.SGD","LU0588546209.SGD","LU0307460666.USD","HK0000320264.USD","LU2045819591.USD","159938","LU1046422090.SGD","LU0516423091.SGD","LU2242644610.SGD","LU0572944931.SGD","LU0039217434.USD","BK1141","01873","01548","LU0348767384.USD","HK0000320223.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641191007","title":"昭衍新药与中国科学院昆明动物研究所签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2641191007","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641191007?lang=zh_cn&edition=full","pubTime":"2026-06-05 11:30","pubTimestamp":1780630244,"startTime":"0","endTime":"0","summary":"近日，北京昭衍新药研究中心股份有限公司与中国科学院昆明动物研究所举行战略合作座谈会暨签约仪式，双方正式签署战略合作框架协议，围绕实验动物资源高值利用、重大疾病动物模型开发、数字生物医药、创新药研发与成果转化等领域开启全面、深度、长期合作。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202606053761716532.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202606053761716532.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["06127","BK1576","BK1141","603127","BK0216"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"stockEarnings":[{"period":"1week","weight":0.0756},{"period":"1month","weight":0.0806},{"period":"3month","weight":-0.0742},{"period":"6month","weight":-0.0158},{"period":"1year","weight":0.1382},{"period":"ytd","weight":-0.0463}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":-0.0891},{"period":"3month","weight":-0.0703},{"period":"6month","weight":-0.1135},{"period":"1year","weight":-0.0299},{"period":"ytd","weight":-0.089}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"北京昭衍新药研究中心股份有限公司是一家主要从事新药药理毒理学研究的中国公司。该公司通过三个分部开展业务。药物非临床研究服务分部主要提供药品非临床安全性评价服务、药效学研究服务、药代动力学研究服务。临床服务及其他分部主要提供药品上市前的临床服务以及药物警戒服务。实验模型供应分部为实验模型及其附属产品的生产和销售。该公司主要在中国国内和海外市场开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.052852},{"month":2,"riseRate":0.6,"avgChangeRate":0.086368},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.020373},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.07562},{"month":5,"riseRate":0.666667,"avgChangeRate":0.065576},{"month":6,"riseRate":0.666667,"avgChangeRate":0.063039},{"month":7,"riseRate":0.833333,"avgChangeRate":0.095017},{"month":8,"riseRate":0,"avgChangeRate":-0.152528},{"month":9,"riseRate":0.6,"avgChangeRate":0.01621},{"month":10,"riseRate":0.2,"avgChangeRate":-0.062964},{"month":11,"riseRate":0.4,"avgChangeRate":0.019565},{"month":12,"riseRate":0.6,"avgChangeRate":0.001933}],"exchange":"SEHK","name":"昭衍新药","nameEN":"JOINN"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,06127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(06127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(06127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}